SCOPUS 정보 검색 플랫폼

European Journal of Pharmacology

Volumn 426, Issue 1-2, 2001, Pages 95-103

Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: Ex vivo evaluation

(5) Giuliano, Francesco a Ferraz, José Geraldo P b Pereira, Renata b De Nucci, Gilberto c Warner, Timothy D a

a QUEEN MARY UNIVERSITY OF LONDON (United Kingdom)

b UNIVERSITY OF CAMPINAS (Brazil)

c UNIVERSITY OF SÃO PAULO (Brazil)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Etodolac; Ex vivo evaluation; Meloxicam; Nabumetone; Naproxen; Nimesulide; Nonsteroid anti inflammatory drug selectivity

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ETODOLAC; LANSOPRAZOLE; MELOXICAM; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; EVALUATION; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ETODOLAC; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; NAPROXEN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; SULFONAMIDES; THIAZINES; THIAZOLES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0035943371 PISSN: 00142999 EISSN: None Source Type: Journal
DOI: 10.1016/S0014-2999(01)01207-9 Document Type: Article

Times cited : (26)

References (26)

1
- 0031753851
- Clinical pharmacokinetics of nimesulide
- (1998) Clin. Pharmacokinet. , vol.35 , pp. 247-274
- Bernareggi, A.¹

2
- 0032727571
- Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: The effect of nimesulide compared with naproxen on the human gastrointestinal tract
- (1999) Rheumatology , vol.38 , Issue.SUPPL. 1 , pp. 24-32
- Bjarnason, I.¹ Thjodleifsson, B.²

3
- 0033404366
- Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: Risk factors and frequency of complications
- (1999) Am. J. Med. , vol.107
- Bjorkman, D.J.¹

4
- 0030939516
- Emergency admissions for upper gastrointestinal disease and their relation to NSAID use
- (1997) Aliment. Pharmacol. Ther. , vol.11 , pp. 283-291
- Blower, A.L.¹ Brooks, A.² Fenn, G.C.³ Pearce, M.Y.⁴ Morant, S.⁵ Bardhan, K.D.⁶

5
- 0031454049
- Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
- (1997) Clin. Pharmacokinet. , vol.33 , pp. 404-416
- Davies, N.M.¹

6
- 0030972931
- Clinical pharmacokinetics of naproxen
- (1997) Clin. Pharmacokinet. , vol.32 , pp. 268-293
- Davies, N.M.¹ Anderson, K.E.²

7
- 0032994274
- Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug
- (1999) Clin. Pharmacokinet. , vol.36 , pp. 115-126
- Davies, N.M.¹ Skjodt, N.M.²

8
- 0032742778
- Meloxicam, 15 mg/day, spares platelet function in healthy volunteers
- (1999) Clin. Pharmacol. Ther. , vol.66 , pp. 425-430
- De Meijer, A.¹ Vollaard, H.² De Metz, M.³ Verbruggen, B.⁴ Thomas, C.⁵ Novakova, I.⁶

9
- 0033451654
- Pharmacology and efficacy of cyclooxygenase (COX) inhibitors
- (1999) Am. J. Med. , vol.107
- Furst, D.E.¹

10
- 0032927066
- Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs
- (1999) Br. J. Pharmacol. , vol.126 , pp. 1824-1830
- Giuliano, F.¹ Warner, T.D.²

11
- 0027185162
- Gastrointestinal toxicity of newer NSAIDs
- (1993) Am. J. Gastroenterol. , vol.88 , pp. 1318-1323
- Lanza, F.L.¹

12
- 0028398324
- Regulation of prostaglandin synthesis by glucocorticoids
- (1994) Receptor , vol.4 , pp. 25-30
- Masferrer, J.L.¹ Seibert, K.²

13
- 0033552526
- Comparative toxicity of nonsteroidal anti-inflammatory drugs
- (1999) Am. J. Med. , vol.107
- McCarthy, D.M.¹

14
- 0032737556
- Cyclo-oxygenase-2: Pharmacology, physiology, biochemistry and relevance to NSAID therapy
- (1999) Br. J. Pharmacol. , vol.128 , pp. 1121-1132
- Mitchell, J.A.¹ Warner, T.D.²

15
- 0027146692
- Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
- (1993) Proc. Natl. Acad. Sci. U. S. A. , vol.90 , pp. 11693-11697
- Mitchell, J.A.¹ Akarasereenont, P.² Thiemermann, C.³ Flower, R.J.⁴ Vane, J.R.⁵

16
- 0027942832
- Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation by dexamethasone
- (1994) Br. J. Pharmacol. , vol.113 , pp. 1008-1014
- Mitchell, J.A.¹ Belvisi, M.G.² Akarasereenont, P.³ Robbins, R.A.⁴ Known, O.-J.⁵ Croxtall, J.⁶ Barnes, P.J.⁷ Vane, J.R.⁸

17
- 0033045831
- Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects
- (1999) J. Pharmacol. Exp. Ther. , vol.290 , pp. 276-280
- Panara, M.R.¹ Renda, G.² Sciulli, M.G.³ Santini, G.⁴ Di Giambernardino, M.⁵ Rotondo, M.T.⁶ Tacconelli, S.⁷ Seta, F.⁸ Patrono, C.⁹ Patrignani, P.¹⁰

18
- 0027940487
- Biochemical and pharmacological characterisation of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases
- (1994) J. Pharmacol. Exp. Ther. , vol.271 , pp. 1705-1712
- Patrignani, P.¹ Panara, M.R.² Greco, A.³ Fusco, O.⁴ Natoli, C.⁵ Iacobelli, S.⁶ Cipollone, F.⁷ Ganci, A.⁸ Créminon, C.⁹ Maclouf, J.¹⁰ Patrono, C.¹¹

19
- 0022396676
- Clinical pharmacology of platelet cyclooxygenase inhibition
- (1985) Circulation , vol.72 , pp. 1177-1184
- Patrono, C.¹ Ciabattoni, G.² Patrignani, P.³ Pugliese, F.⁴ Filabozzi, P.⁵ Catella, F.⁶ Davi, G.⁷ Forni, L.⁸

20
- 0033452430
- Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs)
- (1999) Am. J. Med. , vol.107
- Rainsford, K.D.¹

21
- 0032476569
- Safety profiles of leading nonsteroidal anti-inflammatory drugs
- (1998) Am. J. Med. , vol.105
- Rothstein, R.¹

22
- 0033428384
- Gastrointestinal safety profile of meloxicam: A meta-analysis and systematic review of randomized controlled trials
- (1999) Am. J. Med. , vol.107
- Schoenfeld, P.¹

23
- 0000201176
- Comparative GI toxicity of NSAID
- (1997) Arthritis Rheum. , vol.40 , Issue.SUPPL.
- Singh, G.H.¹ Terry, R.² Ramey, D.R.³ Fries, J.F.⁴ Triadafilopoulos, G.⁵ Halpern, J.⁶ Brown, B.W.⁷

24
- 0033963437
- Quantitative estimation of rare adverse events which follow a biological progression: A new model applied to chronic NSAID use
- (2000) Pain , vol.85 , pp. 169-182
- Tramèr, M.R.¹ Moore, R.A.² Reynolds, D.J.M.³ McQuay, H.J.⁴

25
- 0033673612
- Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers
- (2000) J. Clin. Pharmacol. , vol.40 , pp. 1109-1120
- Van Hecken, A.¹ Schwartz, J.I.² Depre, M.³ De Lepeleire, I.⁴ Dallob, A.⁵ Tanaka, W.⁶ Wynants, K.⁷ Buntinx, A.⁸ Arnout, J.⁹ Wong, P.H.¹⁰ Ebel, D.L.¹¹ Gertz, B.J.¹² De Schepper, P.J.¹³

26
- 0033594911
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
- (1999) Proc. Natl. Acad. Sci. U.S.A. , vol.96 , pp. 7563-7568
- Warner, T.D.¹ Giuliano, F.² Vojnovic, I.³ Bukasa, A.⁴ Mitchell, J.A.⁵ Vane, J.R.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.